Categories: News

Leafbuyer Technologies, Inc. Announces Q3 Results: 46% increase in Quarterly Revenue

Financial Highlights:

  • Quarterly Revenue rose to $984,000 from $672,000 in the third quarter of fiscal year 2021
  • Gross Profit increased to $292,682 from $171,331 in the same period
  • Operating Expenses decreased to $513,469 from $600,733
  • Gross Margins increased 17%

DENVER, CO / ACCESSWIRE / May 17, 2022 / Leafbuyer Technologies, Inc (OTCQB:LBUY) (“Leafbuyer” or “the Company”) a leading cannabis technology and marketing platform, announced today that quarterly revenue rose 46% year over year in the quarter ending March 31, 2022. The increase reflects the GAAP revenue booked in the quarter versus the same quarter of the previous year.

Kurt Rossner, Chief Executive Officer of Leafbuyer, stated, “Our company continues to post growth that is significantly higher than industry averages. The main goals for the remainder of this year will be to continue rapid growth while additionally increasing margins across all product lines. We have several new product launches on the horizon that are super exciting and will hopefully drive significant growth”.

About Leafbuyer Technologies, Inc.

Leafbuyer Technologies is one of the most comprehensive marketing technology providers in the cannabis industry. Hundreds of cannabis businesses use the Leafbuyer texting and loyalty platform and the Custom App solution to engage with current and potential customers. Leafbuyer.com is a robust online resource for cannabis consumers, and the company’s partnerships with other websites have created a national network of cannabis deals and information that reaches millions of consumers every month.

Learn more at http://www.tech.leafbuyer.com

Contact:

Leafbuyer Technologies, Inc.
Vida Almich 720.427.3927
vida@leafbuyertech.com

Cautionary Statement Regarding Forward-Looking Information Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in the forward-looking statements due to several factors detailed from time to time in our filings with the Securities and Exchange Commission. Reference is hereby made to cautionary statements set forth in the Company’s most recent SEC filings.

SOURCE: Leafbuyer Technologies, Inc.

View source version on accesswire.com:
https://www.accesswire.com/701712/Leafbuyer-Technologies-Inc-Announces-Q3-Results-46-increase-in-Quarterly-Revenue

Staff

Recent Posts

Sona Nanotech Announces Filing of Provisional Patent Application

Halifax, Nova Scotia--(Newsfile Corp. - March 18, 2024) - Sona Nanotech Inc. (CSE: SONA), (OTCQB:…

2 hours ago

Rare Element Resources Announces Appointment of Ken Mushinski as President and Chief Executive Officer

LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to…

3 hours ago

Red Light Holland Announces Happy Caps Mushroom Home Grow Kits Now Available in Over 270 Retail Stores Across Canada

Significant increase in number of points of sale (100%) for Happy Caps Mushroom Home Grow…

3 hours ago

Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda

NEWARK, CA / ACCESSWIRE / March 18, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the…

3 hours ago

Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme

PharmAla now first company to supply both MDMA and Psilocybin into the Australian MarketVANCOUVER, British…

3 hours ago